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Abstract 
Hypoxia and oxidative stress are important
factors in the pathogenesis of many acute
forms of injury, especially acute kidney injury.
Apoptosis is a key mode of endothelial cell
death from oxidative stress. Minimising the
detrimental effects of oxidative stress is neces-
sary to reduce injury, and new treatment
strategies are constantly being sought. The
aim of this study was to investigate the ability
of an aqueous/methanol extract of Angelica
sinensis (AS) root (Chinese names Danggui,
Dong quai, Donggui) to protect endothelium
from hypoxia and oxidative stress. This was
compared in specialised kidney endothelium
(renal medullary vascular endothelial cells;
RMVEC) versus central endothelium (aortic
endothelial cells; AEC). Toxicity of various
strengths of AS was first tested in RMVEC and
AEC using % apoptosis and mitosis as out-
comes. Morphological and molecular charac-
teristics of apoptosis and mitosis, and the
effect of AS on heme-oxygenase-1, a marker of
cellular response to oxidative stress, were also
investigated. The results showed that, at con-
centrations of 2500µg/mL or greater, AS signif-
icantly increased apoptosis in RMVEC and AEC
(P<0.05), however concentrations of 2000
µg/mL or less were non-toxic and also non-
mitogenic. Endothelial cells were then treated
with hydrogen peroxide (0.8 mM for RMVEC;
0.6 mM for AEC) for oxidative stress, with and
without 2000 µg/mL AS. AS significantly inhib-
ited oxidant-induced apoptosis (P<0.05) but
had little effect on mitosis. AS also increased
heme-oxygenase-1, but only in AEC. AS
extracts may have some inherent toxicity at
high concentrations, but with careful analysis
of non-toxic levels, both renal and central
endothelium benefited from AS against oxida-
tive stress-induced apoptosis, without induc-
ing excessive mitosis, and AS may find appli-
cation in some oxidant-induced disease.
Introduction
Hypoxia and oxidative stress are important
factors in the pathogenesis of many acute
forms of injury, especially those involving
endothelial cell damage. Acute renal failure
and injury, now termed acute kidney injury
(AKI),1 are particularly important, as the out-
come is death in approximately 30-50% of
cases, especially those in the intensive care
units.2 Many injurious factors contribute to
AKI, but one of the key factors is oxidative
stress.3-6 In the kidney, an important and com-
mon cause of AKI is ischaemia-reperfusion
injury.7 Not only is the tubular epithelium
affected, but also the vascular endothelium,8,9
the latter cell type being particularly prone to
oxidative stress damage. There is some evi-
dence that extracts of the root of Angelica
sinensis (AS) have beneficial effects on human
vascular endothelial cells affected by oxidized
low density lipoprotein.10 In the kidney, AS has
also been used with Astragalus membrana-
ceous for beneficial effect on renal tubular
epithelium after ischemia-reperfusion,11 with
anti-apoptotic, mitogenic and angiogenic
activities noted. Wojcikowski and colleagues
used these combined herbal extracts with the
anti-fibrotic angiotensin-converting enzyme
inhibitor drug enalapril and reported an addi-
tive anti-fibrotic benefit after unilateral
ureteral obstruction.12 However, the effects of
AS on the vascular endothelium are not known,
especially in the acutely-injured kidney. 
With reference to structural changes of AKI,
the relative contributions of necrosis or apop-
tosis vary, depending on the severity of the
damage.4,13 Necrosis causes extensive loss of
renal tubular epithelium, as well as vascular
endothelium, and also initiates an inflamma-
tory response in vivo.14 Apoptosis is thought to
be less damaging, with single cell loss that is
driven by a molecular apoptotic program and
little initiation of acute inflammation.15 In
both cases, if the damage is not too extensive
then the remaining epithelial and endothelial
cells can repair by initiating a regenerative
change. Thus, recovery from AKI depends not
only on the initiation of replacement or regen-
eration of cells deleted by cell death, but also
on minimising cell death. A similar scenario
exists for most ischemia-reperfusion injured
tissues and organs.
This investigation tested the hypothesis
that AS would protect vascular endothelial
cells, particularly those originating from the
kidney, from cell death induced by oxidative
stress, and also restore proliferative or regen-
erative capacity. Because of the reported het-
erogeneity of vascular endothelial cells,16 two
different endothelial cells lines were used so
that a comparison could be made between
renal and major vessel endothelial cells.
Understanding the mechanisms involved in
promotion of regeneration and controlling cell
death processes is crucial to improving patient
outcome from oxidant-induced injury. 
Materials and MethodsCell lines and culture methods
The two characterised cell lines were: rat
renal medullary vascular endothelial cells
(RMVEC; a gift from M. Goligorsky, New York
Medical College, Valhalla NY, USA);17 and
bovine aortic endothelial cells (AEC, American
Type Culture Collection, Rockville, MA, USA).
Both grow as adherent cultures and, for treat-
ments, were grown to 80-90% confluence on
glass coverslips (13 mm diameter; Lomb
Scientific, Taren Point, NSW, Australia) in tis-
sue culture multi-well plates, or in tissue cul-
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ture flasks and Petri dishes in defined growth
medium. RMVEC and AEC were grown in
Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% newborn calf serum
(Trace Scientific, Noble Park, Australia), peni-
cillin (1000 U/mL) and streptomycin (1000
µg/mL) (BioWhittaker, Edward Keller Pty Ltd,
Halam, Australia), in a humidified atmosphere
of 5% carbon dioxide (CO2) in air at 37ºC in a
tissue culture incubator.  Preparation of extracts fromAngelica sinensis
AS root (Chinese names Danggui, Dong
quai, Donggui; Voucher number NCM-D-
07040) was part of a much larger specimen
that had been authenticated by pharmacogno-
sist Mr Hans Wohlmuth, Medicinal Plant
Herbarium, Southern Cross University,
Lismore, Australia. The sample was authenti-
cated by chemical and morphological compari-
son with authenticated reference material.
Voucher samples were deposited in the
Medicinal Plant herbarium and part provided
for use in this project. The sample was of both
upper and lower roots, and was grown in the
Hubei Province in China, in partial shade, and
harvested in mid-autumn after the first year of
growth. The part sample provided for our use
was dried, powdered and then extracted
sequentially with ethyl acetate (10 mL, 3
times), methanol (10 mL, 3 times), and 0%
aqueous methanol (10 mL, 3 times), following
the methods of Wojcikowski et al.18 Figure 1
demonstrates the sequential extraction of AS
to an aqueous: methanol extract (1:1, volume
to volume). The sequential extracts were con-
centrated using a rotary evaporator, and the
dried extracts were then weighed and dis-
solved in dimethyl sulfoxide (DMSO) to make
a final stock concentrations of 100 mg/mL.
These were then stored at 4°C. The
aqueous:methanol extract had greatest anti-
oxidant capacity,18 and this extract was used
for experiments reported here.Cell treatments
Does the aqueous methanol extract of AS
have inherent toxicity? To select a non-toxic
treatment concentration of the aqueous:
methanol extract of AS, this was tested at con-
centrations from 50 to 3000 µg/mL. Control
medium contained DMSO at the volume for
the 3000 µg/mL concentration of AS, that is, at
30 µL/mL medium. Cells were treated for 18-20
h and then assessed for indication of toxicity
(increased apoptosis, decreased mitosis at sig-
nificant levels). The results are detailed later,
but the highest concentration of AS that
caused no increase in toxicity for both cell
lines was 2000 µg/mL. To optimize potential
protective/anti-oxidant effect of AS, this treat-
ment concentration was used for further
experiments. Does AS protect against oxida-
tive stress in vascular endothelium? To model
the effects of oxidative stress on the vascular
endothelium, low levels of hydrogen peroxide
(H2O2) were used as published previously by
us.19,20 These studies had demonstrated that
H2O2 concentrations that caused a significant
increase in apoptosis without loss of adhesion
of non-apoptotic cells, and no necrosis, were
0.8 mM for RMVEC and 0.6 mM for AEC. Thus,
these concentrations were used to cause injury
to renal endothelium that might be considered
similar to in vivo oxidative stress damage.20
Cells were treated with H2O2 with or without
2000 µg/mL AS. Controls had equivalent
amounts of DMSO vehicle as the AS therapy
(20 µL/mL). Cells were analysed at 18-20 h for
apoptosis (morphology, ApopTag) and mitosis
(morphology, proliferating cell nuclear anti-
gen/PCNA). Cell structure: apoptosis and mitosis
Fixation and staining of cells: at the end of
treatment times, cultures were checked for any
cells that had lost adherence from the growth
coverslips or dishes, then the supernatant was
removed, cells on coverslips were washed with
phosphate buffered saline (PBS) pH 7.4, and
fixed in 4% buffered paraformaldehyde for 30
min at 4°C, washed twice with PBS, then
stained routinely for microscopy with haema-
toxylin and eosin (H&E).15 Cells on coverslips
were dehydrated in 100% ethanol, cleared in
xylene, and then mounted onto glass slides
using Depex mounting medium for light mi -
croscopy and photography. 
Apoptosis: Apoptosis was first recognized
microscopically in H&E-stained cells at x200
magnification by its morphological character-
istics. Methods are published previously.15 In
brief, characteristics included shrunken
eosinophilic cells with condensed, marginated
nuclear chromatin and intact cell membrane,
and discrete apoptotic bodies comprising
large, dense, pyknotic nuclear fragments usu-
ally surrounded by a narrow eosinophilic cyto-
plasmic rim. Cells or apoptotic bodies with
nuclear features of apoptosis but showing the
characteristics of secondary degeneration,
similar to necrosis and known to occur in cell
culture,15 were also counted as apoptosis.
Primary necrosis was sought but not observed.
Apoptotic cells were counted in at least 5
microscopic fields with a minimum of 1000
cells counted in total. Counts of apoptosis were
calculated as a percentage of total cells (nor-
mal plus apoptotic) per x200 microscope field.
To verify the presence of apoptosis using bio-
chemical means, the ApopTag® peroxidase in
situ apoptosis detection kit (Serological
Corporation, Millipore Pty Ltd, North Ryde,
Australia), was used according to the suppli-
er's protocol, with appropriate positive and
negative controls. This kit labels apoptotic cells
by modifying DNA fragments utilizing terminal
deoxynucleotidyl transferase for detection of
apoptotic cells by specific staining. 
Mitosis: Mitotic cells were assessed micro-
scopically at x200 in H&E-stained cells on the
basis of spindle formation or cytokinesis.
Formation of mitotic spindles occurs during
metaphase and remains visible in anaphase.
Cells in the latter stage of mitosis (telophase
or undergoing cytokinesis) were also easily
seen. Mitotic cells were counted in at least 5
microscopic fields at x200 magnification and
at least 1000 cells were counted. Counts of
mitosis were calculated as a percentage of
totals cells (normal plus mitotic) per micro-
scope field. The morphological assessment of
mitosis was verified using proliferating cell
nuclear antigen (PCNA) and immunohisto-
chemistry (IHC). IHC methods have been pub-
lished by us previously.21 In brief, PCNA pri-
mary antibody (DAKO, Botany, NSW, Australia;
1:100 dilution) was used in a peroxidase-anti-
peroxidase method. Non-specific binding of
peroxidase or antibody was blocked with 0.3%
H2O2 in 4% skim milk powder followed by incu-
bation in diluted normal rabbit or goat serum.
The peroxidase-anti-peroxidase reaction plus
the chromogen diaminobenzidine tetrahy-
drochloride (DAB) were used for visualization.
Negative controls were prepared without pri-
mary antibody, or with non-specific serum.Protein extraction and analysis ofheme oxygenase-1
HO-1 is a marker of oxidative stress and
anti-oxidant capacity.22 Cultures (control or
treated) for protein extraction were grown in
100 mm2 Petri dishes. Each dish routinely con-
tained a coverslip that was fixed and stained
with H&E to compare morphological changes
with any changes in protein expression meas-
ured by Western immunoblot methods.21 Cells
were washed in ice-cold PBS then disrupted on
ice with RIPA cell lysis buffer containing pro-
tease and phosphatase inhibitors (10 µg/mL
leupeptin, 10μg/mL aprotinin, 100 µg/mL
phenylmethanesulphonyl fluoride, 1 mM sodi-
Article
Figure 1. Extraction process for Angelica
sinensis root. The extraction process lead-
ing to the 50% aqueous:methanol extract,
used as treatment in this model, is demon-
strated.
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um orthovanadate) (Sigma-Aldrich, Botany,
Australia). Cell debris was removed by cen-
trifugation at 16,000 g for 15 min at 4°C and
protein concentration was determined using a
Bradford protein assay and spectroscopy. 40 µg
of total cell lysate were loaded onto each lane.
Protein was resolved using a 10% sodium
dodecylsulphate (SDS) polyacrylamide gel at
100V with a current of 60mAmps, then trans-
ferred to a Polyscreen® polyvinylidene difluo-
ride membrane (Perkin Elmer, Melbourne,
Australia) using a Bio-Rad Mini Protean 3 unit
(Bio-Rad Australia). To prevent non-specific
binding of antibodies, membranes were
blocked in 5% non-fat skim milk in Tris
buffered saline-Tween (TBST) buffer (5% blot-
to) for 1 h at room temperature with gentle
agitation. Membranes were then incubated in
primary antibody (HO-1; StressGen, BC,
Canada; 1:1000) diluted in 5% blotto and incu-
bated overnight at 4°C on a rocking platform.
Blots were washed in TBST then incubated
with horse-radish peroxidase (HRP)-conjugat-
ed secondary antibody diluted 1:2000 in 5%
blotto for 1 h at room temperature. Membranes
were washed in TBST containing 0.1% Igepal
CA-630, and then incubated with Supersignal
West Pico chemiluminescent substrate (Pierce
Biotechnology, Rockford, IL, USA). Protein
bands were detected using enhanced chemilu-
minescence imaging onto X-ray film (Fuji Rx
XR) and scanned using a Hewlett Packard
Scan Jet 3200C at 300 dpi. Scion Image soft-
ware (vβ4.0.2) was used to quantify the densi-
ty of protein bands minus local background in
arbitrary densitometry units. The membranes
were stained with Coomassie blue (Sigma-
Aldrich) to verify equal protein loading of lanes
and protein bands were normalized against
pan-actin using Western blot methods.Statistical analysis
The % apoptosis, mitosis and arbitrary den-
sitometry units were expressed as mean ±
standard error of the mean (SE). All results
were analysed by One-Way Analysis of
Variance (ANOVA) and Dunnet’s multiple com-
parison post-hoc test, where relevant, for com-
parison of 2 or more groups. Significance was
considered to be P<0.05.
Results
Outcome of toxicity and mitosis trial for AS
Serial concentrations of AS (50 to 3000
µg/mL; stock solution 100 µg/µL) were added to
RMVEC and AEC cultures to determine a max-
imal treatment concentration that did not
cause a significant increase in apoptosis,
and/or decrease in mitosis. These results are
presented in Figure 2. In general, AS induced
higher levels of apoptosis at lower levels of AS
in AEC than RMVEC. In RMVEC, at 2500 µg/mL
AS, there was a significant increase in toxicity
of AS (24.0±0.5% apoptosis) compared with
DMSO controls (3.9±1.6%) (P<0.05). There
were no significant differences amongst
scores for mitosis in RMVEC with any of the AS
concentrations. In AEC, there was a gradual
but non-significant rise in apoptosis up to
2000 µg/mL AS, with this increase reaching
significance at 2500 µg/mL AS (11.2±2.1% ver-
sus 2.1±1.5% in DMSO controls, P<0.05). In
addition, there was no significant change in
mitosis to the 2000 µg/mL concentration, after
which there was a negation of mitosis. At 3000
µg/mL AS, there was also loss of cell adhesion
in approximately 50% of cells. Thus, 2000
µg/mL was selected as a non-toxic AS therapy
concentration with potentially the greatest
anti-oxidant ability.18Modulation of oxidative stress-induced endothelial injury by AS 
Figures 3 (bar graphs) and 4 (histology,
ApopTag, PCNA) demonstrate these results.
H2O2 caused a significant increase in apopto-
sis in both cell lines compared with control cul-
tures with DMSO (P<0.05). In both cell lines,
AS caused a significant decline in H2O2-
induced apoptosis (P<0.05). Although AS
returned mitosis, that had been negated by
oxidative stress, to base control levels, it
should be noted that there was also no exces-
sive mitogenesis/angiogenesis from the AS
treatment, something that would have been a
concern for induction of vascular cancers in
the AS-treated cultures without oxidative
stress. Modulation of HO-1 proteinexpression by AS
Figure 5 shows a representative HO-1
Western blot of cell lysates from RMVEC and
AEC treated with H2O2 with or without AS.
RMVECs had strong endogenous HO-1 levels
that were reduced under H2O2 conditions but
were not further altered by AS treatment. The
AS control cultures had expression levels sim-
ilar to DMSO vehicle control cultures. In AEC,
there were low endogenous levels of HO-1
which were not altered by H2O2 but AS pro-
duced a marked increase in HO-1 expression
with or without H2O2, indicating improvement
Article
Figure 2. Toxicity and mitogenesis test of Angelica sinensis. Serial concentrations of AS
(50 to 3000 µg/mL) were added to renal medullary vascular endothelial cells and aortic
endothelial cells to determine a maximal treatment concentration that did not cause sig-
nificant increases in apoptosis, and/or decreases in mitosis. Bar graphs represent mean ±
SE of counts of mitosis and apoptosis following 18-20 h treatment with AS. *Indicates
P<0.05 compared to DMSO control levels.
Figure 3. Effects of Angelica sinensis on oxidative stress-induced injury. Bar graphs rep-
resent means ± SE of counts for apoptosis and mitosis for oxidative stress with and with-
out AS in renal medullary vascular endothelial cells (RMVEC) and aortic endothelial
cells (AEC). *Indicates P<0.05 compared to H2O2 treated cultures. H2O2 caused a signif-
icant increase in apoptosis in both cell lines. AS caused a significant decline in apoptosis
induced by oxidative stress. Although AS returned mitosis to base control levels, it did
not increase mitosis above control levels in either cell line with oxidative stress.
No
n-c
om
me
rci
al 
us
e o
nly
[Alternative Medicine Studies 2011; 1:e8] [page 33]
in anti-oxidant capacity with AS. 
Discussion
The root of AS is an important Chinese med-
icine, tradionally used for treatment of blood
disorders such as anaemia, and other human
health problems such as amenorrhea, hyperten-
sion and other cardiovascular disorders, asth-
ma, bronchitis, and rheumatism.23 Extracts of
the root of AS have been reported to have bene-
ficial effects on human vascular endothelium
affected by oxidized low density lipoprotein.10
The active ingredients of AS root, determined by
gas chromatography-mass spectroscopy, are
thought to be ferulic acid, ligustilide and other
phthalides such as butylidenephthalide, but oth-
ers may be involved in AS activity. The levels of
these constituents are known to be variable,
depending on the region and climate where the
plants were grown.23 Nonetheless AS root,
known best as Danggui, is in great demand
throughout the world.
One of the concerns of medicinal herbal
usage is that there may be a toxic effect on dif-
ferent cellular components of the body, particu-
larly the kidney.24 In these experiments, we
have demonstrated that AS therapy may have
some inherent toxicity at high concentrations,
but at moderate levels it protected both renal
and central vascular endothelium against oxida-
tive stress-induced apoptosis, did not induce
excessive mitosis, and had differences in out-
come between renal and central endothelium in
the induction of HO-1. These findings suggest
that AS confers cytoprotection against oxidative
stress-induced apoptosis and this beneficial
effect is, at least in part, mediated through an
antioxidant function. Thus, the results are in
good agreement with previous findings show-
ing that AS extracts prevented cell death or
apoptosis, in many cases induced by oxidative
stress, in neuronal, gut, cardiac, and renal
epithelial cells.11,25-27 The anti-oxidant ability of
AS has been published previously, using various
oxidative stress tests.18,28
Although both nephrotoxicity and ischemia-
reperfusion are common causes of AKI involv-
ing oxidative stress,13 ischemia-reperfusion is
the more common cause of injury.7 Mecha nisms
for development of renal dysfunction and injury
in ischaemia-reperfusion-induced AKI involve
apoptosis and necrosis, and inflammation. Thus
the present study, involving cytoprotection of
the renal vascular endothelium by AS, is partic-
ularly relevant. No vascular endothelial necrosis
was detected, but the significantly increased
levels of apoptosis induced by oxidative stress
were normalized completely by the concurrent
AS treatment. Cytoprotection of the vasculature
may provide some anti-inflammatory potential,
whereby a reduction in vascular destruction and
leakiness during injury reduces the efflux of
leucocytes to the point of injury. This is thought
to be one of the reasons for exacerbation of
renal injury during AKI,14 and perhaps one of
the reasons why AS therapy might be protective.
Ischemia-reperfusion also exacerbates vaso -
spasm and thus is a critical determinant of the
extent of ischemic organ injury.29 One could
speculate that cytoprotection of the renal vascu-
lar endothelium by AS has the potential to
improve overall health by reducing the local
ischemic organ injury.
HO-1 is a 32 kDa protein known to be upreg-
ulated in response to stress such as oxidative
stress, and protect against cell death.22,30 HO-1
is the first and rate limiting enzyme that cataly-
ses heme degradation to biliverdin, liberating
carbon monoxide and free iron in the process. It
is likely that the anti-oxidant capacity of AS
could be indicated not only by amelioration of
cell damage induced by oxidative stress, but
also stimulation of HO-1 with AS therapy. The
mechanisms by which HO-1 counteracts oxida-
tive stress and apoptosis in vascular endotheli-
um following AKI remain unclear. A recent study
demonstrated that a truncated form of HO-1 is
translocated into the nucleus of cells after
hypoxic exposure. This translocation activated
oxidant responsive transcription factors and
protected cells against H2O2-mediated injury.25
Thus, analysis of nuclear HO-1 should be con-
sidered in future studies of mechanisms of anti-
oxidant protection by AS. Modulation of HO-1
has also been shown to have anti-inflammatory
therapy potential,30 and this mechanism is aug-
mented by AS treatment. 
Conclusions
AS treatment may provide significant pro-
tection against oxidative stress-induced cyto-
toxicity in renal and central vascular endothe-
lium, without causing excessive angiogenesis.
The present study demonstrated, for the first
time, that antioxidant and anti-apoptotic prop-
erties of AS may contribute to its protective
potential in oxidative damage to renal vascular
endothelium. 
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